Learning curve of combined modality treatment in peritoneal surface disease - Concepedia

Concepedia

Publication | Open Access

Learning curve of combined modality treatment in peritoneal surface disease

DOI Full Paper Access

219

Citations

29

References

2007

Year

Robert M. Smeenk, Victor J. Verwaal, F.A.N. Zoetmulder

British journal of surgery

Abstract

The learning curve of combined modality treatment for peritoneal surface disease is long, and reflects patient selection and treatment expertise.

References

	Year	Citations
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer Victor J. Verwaal, Serge van Ruth, Eelco de Bree, Journal of Clinical Oncology	2003	2K
Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study Olivier Gléhen, Fabrice Kwiatkowski, Paul H. Sugarbaker, Journal of Clinical Oncology	2004	1.2K
A Clinicopathologic Analysis of 109 Cases with Emphasis on Distinguishing Pathologic Features, Site of Origin, Prognosis, and Relationship to “Pseudomyxoma Peritonei” Brigite M. Ronnett, Christopher M. Zahn, Robert J. Kurman, The American Journal of Surgical Pathology Tumoral PathologyPseudomyxoma Peritonei ”MedicineSurgical PathologyHistopathology	1995	780
Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique Arvil D. Stephens, Robert Alderman, David Chang, Annals of Surgical Oncology Mortality AnalysisColiseum TechniqueCytoreductive SurgerySurgical OncologyMedicine	1999	387
Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis Brigitte M. Ronnett, Hui Yan, Robert J. Kurman, Cancer	2001	381
Prospective Morbidity and Mortality Assessment of Cytoreductive Surgery Plus Perioperative Intraperitoneal Chemotherapy To Treat Peritoneal Dissemination of Appendiceal Mucinous Malignancy Paul H. Sugarbaker, Robert Alderman, Gary Edwards, Annals of Surgical Oncology Surgical OncologyGastrointestinal OncologyColorectal SurgeryMortality AssessmentMedicine	2006	268
Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Robert M. Smeenk, Victor J. Verwaal, Ninja Antonini, Annals of Surgery	2006	266
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion Shigeki Kusamura, Rami Younan, Dario Baratti, Cancer	2006	253
Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome Paul H. Sugarbaker European Journal of Surgical Oncology Cytoreductive SurgerySurgical OncologyPeritonei SyndromePeri-operative Intraperitoneal ChemotherapyPathology	2001	253
Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy Pierre O. Jacquet, Arvil D. Stephens, Andrew Averbach, Cancer	1996	231

Page 1